about
Sinus versus nonsinus tachycardia in the emergency department: importance of age and heart rateComparison of outcomes using sirolimus-eluting stenting in diabetic versus nondiabetic patients with comparison of insulin versus non-insulin therapy in the diabetic patientsStent thrombosis in randomized clinical trials of drug-eluting stentsThe National Cardiovascular Data Registry (NCDR) Data Quality Brief: the NCDR Data Quality Program in 2012.Enhanced mortality risk prediction with a focus on high-risk percutaneous coronary intervention: results from 1,208,137 procedures in the NCDR (National Cardiovascular Data Registry).Cardiac biomarker measurement after elective percutaneous coronary interventions in older patients: insights from the National Cardiovascular Data Registry.Magnetic resonance imaging demonstrates improved regional systolic wall motion and thickening and myocardial perfusion of myocardial territories treated by laser myocardial revascularization.The data extraction and longitudinal trend analysis network study of distributed automated postmarket cardiovascular device safety surveillanceUtility of patient-activated cardiac event recorders in general clinical practice.A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators.Contemporary mortality risk prediction for percutaneous coronary intervention: results from 588,398 procedures in the National Cardiovascular Data RegistryImprovement in mortality risk prediction after percutaneous coronary intervention through the addition of a "compassionate use" variable to the National Cardiovascular Data Registry CathPCI dataset: a study from the Massachusetts Angioplasty RegistrHolter monitoring: are two days better than one?Variation in the utilization of antiarrhythmic drugs in patients with new-onset atrial fibrillation.Effect of gender on in-hospital and one-year outcomes after contemporary coronary artery stenting.Risk factors for nosocomial gastrointestinal bleeding and use of acid-suppressive medication in non-critically ill patients.Utility of a real-time appropriate use criteria decision support application for percutaneous coronary interventions in non-acute coronary syndrome.Type 4a myocardial infarction: Incidence, risk factors, and long-term outcomes.Economics of elective coronary revascularization. Comparison of costs and charges for conventional angioplasty, directional atherectomy, stenting and bypass surgery.Results of the study to determine rotablator and transluminal angioplasty strategy (STRATAS).Quality assessment and improvement in interventional cardiology: a Position Statement of the Society of Cardiovascular Angiography and Interventions, Part II: public reporting and risk adjustment.Clinical presentation, management, and outcomes of angiographically documented early, late, and very late stent thrombosis.Risk assessment for percutaneous coronary intervention: our version of the weather report?Effects of stent length and lesion length on coronary restenosis.Rheolytic thrombectomy and platelet glycoprotein IIb/IIIa blockade for stent thrombosis.Comparison of rotational atherectomy with conventional balloon angioplasty in the prevention of restenosis of small coronary arteries: results of the Dilatation vs Ablation Revascularization Trial Targeting Restenosis (DART).Platelet glycoprotein IIb/IIIa inhibition with eptifibatide: prolongation of inhibition of aggregation in acute renal failure and reversal with hemodialysis.Differential mortality risk of postprocedural creatine kinase-MB elevation following successful versus unsuccessful stent procedures.Predictive factors for ischemic target vessel revascularization in the Prevention of Restenosis with Tranilast and its Outcomes (PRESTO) trial.Clinical, procedural, and pharmacologic correlates of acute and subacute stent thrombosis: results of a multicenter case-control study with 145 thrombosis events.Differential outcomes after sirolimus-eluting stent implantation: comparing on-label versus off-label patients in the 'real world'.Geographical differences in the rates of angiographic restenosis and ischemia-driven target vessel revascularization after percutaneous coronary interventions: results from the Prevention of Restenosis With Tranilast and its Outcomes (PRESTO) Trial.Impact of a practice guideline for patients with atrial fibrillation on medical resource utilization and costs.Safety and effectiveness of stent implantation without predilation for small coronary arteries.The Carotid Artery Revascularization and Endarterectomy (CARE) registry: objectives, design, and implications.ACC/AHA 2008 statement on Performance Measurement and Reperfusion Therapy: a report of the ACC/AHA Task Force on Performance Measures (Work Group to address the challenges of Performance Measurement and Reperfusion Therapy).Effect of diabetes mellitus on five-year clinical outcomes after single-vessel coronary stenting (a pooled analysis of coronary stent clinical trials).Initial impact of drug-eluting stents on coronary artery bypass graft surgery.Obesity and clinical restenosis after coronary stent placement.Effect of continuous quality improvement analysis on the delivery of primary percutaneous transluminal coronary angioplasty for acute myocardial infarction.
P50
Q24795392-5B5AB730-63A4-4B42-8632-659BF5FAFF2AQ28252387-68B6C3A8-E54A-4510-B040-7784F3A510C5Q28287921-7324E52E-C125-4DFE-8BF2-46C8D7380007Q30570004-3F6721A1-3D8B-4046-88AE-F0EBAC064CF3Q30662929-8059585E-D0D1-4B44-8647-1653E1B81B27Q30686916-77FE74D0-AA4D-4D1B-B7FE-5D8A7D83B271Q30783874-E4E3BF68-EB21-451E-8A58-AD08E43FE773Q30876776-4F6C86B1-C7DC-4341-86EC-56F3CD8D1DB6Q33175026-CC2E8579-4C80-45A2-A6E1-FA0FA43AECF0Q33504515-2376E3DA-0EDF-4F52-9451-1E43C6ED66B8Q33568223-7C571DDA-30E2-4C52-9652-67C33AF4C353Q33823322-6E0DAA0D-05B8-40B1-8BDF-6AA2E6117236Q34048156-4916F439-800B-4BC3-9436-DDFC7BC90E06Q35035767-3E953587-CBF1-4672-8D43-661BDC4DF704Q35993716-7B6A4407-4265-4B7A-81BE-7DEF1AD82BCDQ36780226-25671624-2C7A-4404-BFA7-E782C0281F19Q38677705-2C856548-63F2-4A63-95C6-8DC481F966F4Q38930286-902D9AB2-4679-4B5E-A001-AD201B9C2404Q41065425-5615C6A2-FB60-4B98-A9C1-DFC1FFA64CB2Q42045780-C22FB084-359C-4259-BACF-9CADF8C542D8Q43589876-0410DB07-9374-4340-BF29-F9D0EC51AC02Q43920495-C3DC6753-825E-4434-9BAD-EC578384C832Q43947219-5EA15240-E455-4787-A1D6-2D071946265FQ44021153-77471980-B152-4183-8C17-57726699A0FDQ44120107-37497B4B-D5FF-45B8-805D-970532999384Q44453736-90D86F29-1173-455A-B4C0-2E244C79AF46Q44532976-F0B1E28F-2A55-48EE-B468-DC6EE4F05BADQ45056643-98BB0ECA-5EC9-4C59-A155-8147362381F4Q45226100-28A3D0C6-1CD4-4DD7-B823-C833E3F8F54EQ46678659-39F46953-7BA1-4203-B271-5288CE807564Q46733046-47AF716C-A357-4BEE-BA92-5E255B451C41Q46874061-D2CA6EDA-DB74-4C7B-9FEB-A621D0D93715Q47628272-7178BACF-61D9-42E5-9756-15B11D36B2A5Q47723214-1D35F079-837E-4EE7-A60E-8E667265839FQ47773761-19AABA89-4BAC-4FB4-83DF-C5ED5B41484BQ50610542-335AFC27-973E-4E7C-965B-94455EB679A3Q51137645-75ADE4B2-73E5-4F7B-A1AD-13699B19BFD9Q51241159-CCEB038B-B79D-491E-A5DB-A12DD98A11D7Q51342656-CE3155A5-C5C4-4102-8145-0F9F05054940Q51543468-9EA545DD-2048-42D6-9234-89D7B770FE8D
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Kalon Ho
@ast
Kalon Ho
@en
Kalon Ho
@es
Kalon Ho
@nl
Kalon Ho
@sl
type
label
Kalon Ho
@ast
Kalon Ho
@en
Kalon Ho
@es
Kalon Ho
@nl
Kalon Ho
@sl
prefLabel
Kalon Ho
@ast
Kalon Ho
@en
Kalon Ho
@es
Kalon Ho
@nl
Kalon Ho
@sl
P106
P31
P496
0000-0001-5946-6428